Decreased lipin 1β expression in visceral adipose tissue is associated with insulin resistance in polycystic ovary syndrome

European Journal of Endocrinology

Volumn 159, Issue 6, 2008, Pages 833-839

  Mlinar, Barbara ^a   Pfeifer, Marija ^b   Vrtačnik Bokal, Eda ^b   Jensterle, Mojca ^b   Marc, Janja ^a  

^a UNIVERSITY OF LJUBLJANA   (Slovenia)

^b UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; CELL PROTEIN; GLUCOSE TRANSPORTER 4; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HORMONE SENSITIVE LIPASE; LIPIN 1BETA; LIPOPROTEIN LIPASE; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; LPIN1 PROTEIN, HUMAN; NUCLEAR PROTEIN;

ADULT; ARTICLE; BIOPSY; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; INSULIN RESISTANCE; INTRAABDOMINAL FAT; MAJOR CLINICAL STUDY; OVARY POLYCYSTIC DISEASE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SUBCUTANEOUS FAT; TISSUE SPECIFICITY; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; BIOSYNTHESIS; COMPARATIVE STUDY; DRUG ANTAGONISM; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PHYSIOLOGY;

ADULT; FEMALE; GENE EXPRESSION REGULATION; HUMANS; INSULIN RESISTANCE; INTRA-ABDOMINAL FAT; NUCLEAR PROTEINS; POLYCYSTIC OVARY SYNDROME; YOUNG ADULT;

EID: 58149350322     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-08-0387     Document Type: Article

References (29)

1. Kousta E, Tolis G & Franks S. Polycystic ovary syndrome. Revised diagnostic criteria and long-term health consequences. Hormones 2005 4 133-147.
2. Mlinar B, Marc J, Janez A & Pfeifer M. Molecular mechanisms or insulin resistance and associated diseases. Clinica Chimica Acta 2007 375 20-35.
3. Puder JJ, Varga S, Kraenzlin M, De Geyter C, Keller U & Muller B. Central fat excess in polycystic ovary syndrome: relation to lowgrade inflammation and insulin resistance. Journal of Clinical Endocrinology and Metabolism 2005 90 6014-6021.
4. Donkor J, Sariahmetoglu M, Dewald J, Brindley DN & Reue K. Three mammalian lipins act as phosphatidate phosphatases with distinct tissue expression patterns. Journal of Biological Chemistry 2007 282 3450-3457.
5. Finck BN, Gropler MC, Chen Z, Leone TC, Croce MA, Harris TE, Lawrence JC Jr & Kelly DF. Lipin 1 is an inducible amplifier of the hepatic PGC-lalpha/PPARalpha regulatory pathway. Cell Metabolism 2006 4 199-210.
6. Peterfy M, Phan J, Xu P & Reue K. Lipodystrophy in the fld mouse results from mutation of a new gone encoding a nuclear protein, lipin. Nature Genetics 2001 27 121-124.
7. Peterfy M, Phan J & Reue K. Alternatively spliced lipin isoforms exhibit distinct expression pattern, subcellular localization, and role in adipogenesis. Journal of Biological Chemistry 2005 280 32883-32889.
8. Suviolahti E, Reue K, Cantor RM, Phan J, Gentile M, Naukkarinen J, Soro-Paavonen A, Oksanen L, Kaprio J, Rissanen A, Salomaa V, Kontula K, Taskinen MR, Pajukanta P & Peltonen L. Cross-species analyses implicate Lipin 1 involvement in human glucose metabolism. Human Molecular Genetics 2006 15 377-386.
9. Yao-Borengasser A, Rasouli N, Varma V, Miles LM, Phanavanh B, Starks TN, Phan J, Spencer HJ III, Mcgehee RE Jr, Reue K & Kern PA, Lipin expression is attenuated in adipose tissue of insulinresistant human subjects and increases with peroxisome proliferator- activated receptor gamma activation. Diabetes 2006 55 2811-2818.
10. Van Harmelen V, Ryden M, Sjolin E & Hoffstedt J. A role of lipin in human obesity and insulin resistance: relation to adipocyte glucose transport and GLUT4 expression. Journal of Lipid Research 2007 48 201-206.
11. Croce MA, Eagon JC, Lariviere U, Korenblat KM, Klein S & Finck BN. Hepatic lipin 1 beta expression is diminished in insulinresistant obese subjects and is reactivated by marked weight loss. Diabetes 2007 56 2395-2399.
12. Donkor J, Sparks LM, Xie H, Smith SR & Reue K. Adipose tissue Lipin-1 expression is correlated with peroxisome proliferatoractivated receptor α gene expression and insulin sensitivity in healthy young men. Journal of Clinical Endocrinology and Metabolism 2008 93 233-239.
13. Bergman RN, Kim SP, Catalano KJ, Hsu IR, Chin JD, Kabir M, Hucking K & Ader M. Why visceral fat is bad: mechanisms of the metabolic syndrome. Obesity 2006 14 (Suppl 1) 16S-19S.
14. Carey VJ, Walters EE, Colditz GA, Solomon CG, Willett WC, Rosner BA, Speizer FE & Manson JE. Body fat distribution and risk of non-insulin-dependent diabetes mellitus in women. The Nurses' Health Study. American Journal of Epidemiology 1997 145 614-619.
15. Rexrode KM, Carey VJ, Hennekens CH, Walters EE, Colditz GA, Stampfer MJ, Willett WC & Manson JE. Abdominal adiposity and coronary heart disease in women. Journal of the American Medical Association 1998 280 1843-1848.
16. Zawadski JK & Dunaif A. Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. In Polycystic Ovary Syndrome, pp 377-384. Eds A Dunaif, JR Givens, FP Haseltine & GR Merriam. Boston, MA: Blackwell Scientific Publications, 1992.
17. Mavri A, Alessi MC, Bastelica D, Geel-Georgelin O, Fina F, Sentocnik JT, Stegnar M & Juhan-Vague I. Subcutaneous abdominal, but not femoral fat expression of plasminogen activator inhibitor-1 (PAI-1) is related to plasma PAI-1 levels and insulin resistance and decreases after weight loss. Diabetologia 2001 44 2025-2031.
18. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF & Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985 28 412-419.
19. Chen X, Yang D, Li L, Feng S & Wang L. Abnormal glucose tolerance in Chinese women with polycystic ovary syndrome. Human Reproduction 2006 21 2027-2032.
20. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A & Speleman E Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biology 2002 3 RESEARCH0034.
21. Berneis K, Rizzo M, Lazzarini V, Fruzzetti F & Carmina E. Atherogenic lipoprotein phenotype and low-density lipoproteins size and subclasses in women with polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism 2007 92 186-189.
22. Tchernof A, Belanger C, Morisset AS, Richard C, Mailloux J, Laberge P & Dupont P. Regional differences in adipose tissue metabolism in women: minor effect of obesity and body fat distribution. Diabetes 2006 55 1353-1360.
23. Laplante M, Sell H, Macnaul KL, Richard D, Berger JP & Deshaies Y. PPAR-gamma activation mediates adipose depotspecific effects on gene expression and lipoprotein lipase activity: mechanisms for modulation of postprandial lipemia and differential adipose accretion. Diabetes 2003 52 291-299.
24. Festuccia WT, Laplante M, Berthiaume M, Gelinas Y & Deshaies Y. PPARgamma agonism increases rat adipose tissue lipolysis, expression of glyceride lipases, and the response of lipolysis to hormonal control. Diabetologia 2006 49 2427-2436.
25. Iwaki M, Matsuda M, Maeda N, Funahashi T, Matsuzawa Y, Makishima M & Shimomura I. Induction of adiponectin, a fatderived antidiabetic and antiatherogenic factor, by nuclear receptors. Diabetes 2003 52 1655-1663.
26. Langner CA, Birkenmeier EH, Ben-Zeev O, Schotz MC, Sweet HO, Davisson MT & Gordon JI. The fatty liver dystrophy (fld) mutation. A new mutant mouse with a developmental abnormality in triglyceride metabolism and associated tissue-specific defects in lipoprotein lipase and hepatic lipase activities. Journal of Biological Chemistry 1989 264 7994-8003.
27. Rene K, Xu P, Wang XP & Slavin BG. Adipose tissue deficiency, glucose intolerance, and increased atherosclerosis result from mutation in the mouse fatty liver dystrophy (fld) gene. Journal of Lipid Research 2000 41 1067-1076.
28. Jensterle M, Janez A, Mlinar B, Marc J, Prezelj J & Pfeifer M. Impact of metformin and rosiglitazone treatment on glucose transporter 4 mRNA expression in women with polycystic ovary syndrome. European Journal of Endocrinology 2008 158 793-801.
29. Nestler JE, Powers LP, Matt DW, Steingold KA, Plymate SR, Rittmaster RS, Clore JN & Blackard WG. A direct effect of hyperinsulinemia on serum sex hormone-binding globulin levels in obese women with the polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism 1991 72 83-89.